DOYLE JOHN BRENDAN (Chief Financial Officer) received a stock award from COGNITION THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/31/2025ACC: 0001062993-25-013357
Officer· Chief Financial Officer
Since Feb 2026
+20.64K
Net shares
Net buyer
$6.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
30K acquired · 9.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
7.4%
7/29/2025
404.71K→434.71K
Common Stock
Direct
Shares
−9.36K
Price / share
$0.67
Trade value
$6.27K
% of position
2.2%
7/29/2025
434.71K→425.35K
Total
Net shares
+20.64K
Net value
-$6.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/29/2025 | A · Award | +30K | — | — | 7.4% | 404.71K | 434.71K |
| Common Stock Direct | 7/29/2025 | F · Tax Withholding | −9.36K | $0.67 | $6.27K | 2.2% | 434.71K | 425.35K |
| Total | +20.64K | -$6.27K | ||||||
Derivative Transactions0
No derivative transactions reported